Severe subacute onset sensorimotor polyneuropathy associated with brentuximab vedotin treatment for refractory classical Hodgkin's lymphoma.

MLA

McNicholas, Nuala, et al. “Severe Subacute Onset Sensorimotor Polyneuropathy Associated with Brentuximab Vedotin Treatment for Refractory Classical Hodgkin’s Lymphoma.” BMJ Case Reports, vol. 17, no. 11, Nov. 2024. EBSCOhost, https://doi.org/10.1136/bcr-2024-262139.

APA

McNicholas, N., Hiew, H. J., Arunachalam, R., & Osman, C. (2024). Severe subacute onset sensorimotor polyneuropathy associated with brentuximab vedotin treatment for refractory classical Hodgkin’s lymphoma. BMJ Case Reports, 17(11). https://doi.org/10.1136/bcr-2024-262139

Chicago

McNicholas, Nuala, Hwai Jing Hiew, Ramamurthy Arunachalam, and Chinar Osman. 2024. “Severe Subacute Onset Sensorimotor Polyneuropathy Associated with Brentuximab Vedotin Treatment for Refractory Classical Hodgkin’s Lymphoma.” BMJ Case Reports 17 (11). doi:10.1136/bcr-2024-262139.